Search results
Medicare’s push to improve chronic care attracts businesses, but not many doctors
Boston Herald· 3 days agoCarrie Lester looks forward to the phone call every Thursday from her doctors’ medical assistant,...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 4 days agoThat figure did not include rebates or other discounts negotiated by pharmacy benefit managers....
TONI SAYS: Why is Medicare Part D’s IRMAA premium so high?
Odessa American· 5 days agoRecently I received a letter from Social Security telling me that my monthly Medicare Part B premium of $174.700 would double to $349.40 per month due to 2022< ...
3.6 million Medicare enrollees may now be eligible for Wegovy coverage
CNN via Yahoo News· 5 days agoAbout 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy,...
Medicare Advantage insurers mull Wegovy coverage ‘trade-offs’
Modern Healthcare· 4 days agoMedicare Advantage insurers are weighing coverage of pricey new anti-obesity drugs after federal regulators last month announced traditional Medicare would ...
3.6 million Medicare enrollees may now be eligible for Wegovy coverage
WTAE Pittsburgh· 5 days agoAbout 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy,...
Janelle Bynum and Jamie McLeod-Skinner compete for Democratic nomination in 5th District
Gannett via AOL· 16 hours agoExpanding access to quality, affordable health care Bynum said she would protect Medicare, expand...
Did you know that 1 in 4 Americans over 50 don't expect to retire?
KNBN Rapid City· 3 days agoMore than one-quarter of U.S. adults over age 50 say they expect to never retire and 70% are...
Big wins and losses for ASCs
Becker's ASC Review· 4 days agoAccording to the 2023 OR Manager survey, ASC leaders saw an increase in compensation in 2023, with 68% of respondents reporting a total annual compensation of $120,000 or ...
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 2 days agoNonetheless, Vabysmo, approved for wet macular degeneration in 2022, reported a tripling of drug...
